Contributed By Walder Wyss Ltd
Healthcare institutions in Switzerland generally do not need to prepare budgets for medicines because the majority of medicines are listed in the “list of specialities” (SL) and therefore reimbursed by compulsory healthcare insurances. The prices of these listed medicines are determined by the authorities, generally after their approval and before their release on the Swiss market. Consequently, there is no reason to send information on unauthorised medicines or unauthorised indications to healthcare institutions solely for budget reasons. It is thus likely that such information would be considered to be prohibited advertising to the public (Article 16 paragraph. 1 AWV).